Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 336

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon

Merkel, Peter A., Herlyn, Karen, Martin, Richard W., Anderson, Jennifer J., Mayes, Maureen D., Bell, Patrice, Korn, Joseph H., Simms, Robert W., Csuka, Mary Ellen, Medsger, Thomas A., Rothfield, Naomi F., Ellman, Michael H., Collier, David H., Weinstein, Arthur, Furst, Daniel E., Jiménez, Sergio A., White, Barbara, Seibold, James R., Wigley, Fredrick M., for the Scleroderma Clinical Trials Consortium · 2002 · Arthritis & Rheumatism

Abstract

Objective: To document disease activity and functional status in patients with scleroderma (systemic sclerosis [SSc]) and Raynaud's phenomenon (RP) and to determine the sensitivity to change, reliability, ease of use, and validity of various outcome measures in these patients. Methods: Patients with SSc and moderate‐to‐severe RP participating in a multicenter RP treatment trial completed daily diaries documenting the frequency and duration of RP attacks and recorded a daily Raynaud's Condition Score (RCS). Mean scores for the 2‐week periods prior to baseline (week 0), end of trial (week 6), and posttrial followup (week 12) were calculated. At weeks 0, 6, and 12, physicians completed 3 global assessment scales and performed clinical assessments of digital ulcers and infarcts; patients completed the Health Assessment Questionnaire (HAQ), the Arthritis Impact Measurement Scales 2 (AIMS2) mood and tension subscales, 5 specific SSc/RP‐related visual analog scales (VAS), and 3 other VAS global assessments. We used these measures to document baseline disease activity and to assess their construct validity, sensitivity to change, and reliability in trial data. Results: Two hundred eighty‐one patients (248 women, 33 men; mean age 50.4 years [range 18–82 years]) from 14 centers participated. Forty‐eight percent had limited cutaneous SSc; 52% had diffuse cutaneous SSc. Fifty‐nine patients (21%) had digital ulcers at baseline. Patients had 3.89 ± 2.33 (mean ± SD) daily RP attacks (range 0.8–14.6), with a duration of 82.1 ± 91.6 minutes/attack. RCS for RP activity (possible range 0–10) was 4.30 ± 1.92. HAQ scores (0–3 scale) indicated substantial disability at baseline (total disability 0.86, pain 1.19), especially among the subscales pertaining to hand function (grip, eating, dressing). AIMS2 mood and tension scores were fairly high, as were many of the VAS scores. Patients with digital ulcers had worse RCS, pain, HAQ disability (overall, grip, eating, and dressing), physician's global assessment, and tension, but no significant difference in the frequency of RP, duration of RP, patient's global assessment, or mood, compared with patients without digital ulcers. VAS scores for digital ulcers as rated by the patients were not consistent with the physician's ratings. Factor analysis of the 18 measures showed strong associations among variables in 4 distinct domains: disease activity, RP measures, digital ulcer measures, and mood/tension. Reliability of the RCS, HAQ pain and disability scales, and AIMS2 mood and tension subscales was high. The RP measures demonstrated good sensitivity to change (effect sizes 0.33–0.76). Conclusion: Our findings demonstrate that the significant activity, disability, pain, and psychological impact of RP and digital ulcers in SSc can be measured by a small set of valid and reliable outcome measures. These outcome measures provide information beyond the quantitative metrics of RP attacks. We propose a core set of measures for use in clinical trials of RP in SSc patients that includes the RCS, patient and physician VAS ratings of RP activity, a digital ulcer/infarct measure, measures of disability and pain (HAQ), and measures of psychological function (AIMS2).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/art.10486

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 25 references

Cited by

Metadata

Authors
Merkel, P. A., Herlyn, K., Martin, R. W., Anderson, J. J., Mayes, M. D., Bell, P., Korn, J. H., Simms, R. W., Csuka, M. E., Medsger, T. A., Rothfield, N. F., Ellman, M. H., Collier, D. H., Weinstein, A., Furst, D. E., Jiménez, S. A., White, B., Seibold, J. R., Wigley, F. M., & for the Scleroderma Clinical Trials Consortium
Venue
Arthritis & Rheumatism
Publisher
Wiley
Published
2002-09
Volume
46
Issue
9
Pages
2410-2420
ISSN
  • 0004-3591 (ISSN-L)
  • 1529-0131
OpenAlex
W2054504088
Cited by
336
References
25
FWCI
4.77
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.